Literature DB >> 25562163

TGF-β1 promotes osteosarcoma cell migration and invasion through the miR-143-versican pathway.

Fengfeng Li1, Shaohua Li, Tao Cheng.   

Abstract

BACKGROUND & AIMS: TGF-β1 is an abundant cytokine present in the tumour microenvironment. It has been shown to trigger versican expression in human osteosarcoma cells, which may account for the metastatic potential of these cells. However, the underlying mechanism of TGF-β1-mediated metastasis remains unclear. The aim of this study was to evaluate the roles of versican in TGF-β1-induced osteosarcoma cell migration and invasion.
METHODS: Sixty paired osteosarcoma tumour tissues and adjacent normal tissues were obtained, and the relationship between Enneking stage and versican expression was tested by ANOVA analysis. Real-time PCR or Western blot was used to detect versican, Smad and miR-143 expression. Osteosarcoma cell migration and invasion was assessed using Boyden chambers. A luciferase reporter assay was employed to validate the miR-143-versican interaction.
RESULTS: Both versican isoforms, V0 and V1, were significantly differentially expressed in tumours at different stages. TGF-β1 promoted osteosarcoma cell migration and invasion in vitro by up-regulating versican. Furthermore, TGF-β1 suppressed miR-143 expression through a Smad 2/3-dependent pathway. miR-143 directly targets the versican 3'-UTR, and anti-miR-143 or versican knockdown blocked the effects of TGF-β1.
CONCLUSION: Our results suggest that TGF-β1 up-regulates versican expression by suppressing miR-143, and this pathway is important for osteosarcoma cell migration and invasion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25562163     DOI: 10.1159/000369660

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  23 in total

1.  Enhanced Wnt signaling by methylation-mediated loss of SFRP2 promotes osteosarcoma cell invasion.

Authors:  Qiang Xiao; Yu Yang; Xuepu Zhang; Qing An
Journal:  Tumour Biol       Date:  2015-12-01

Review 2.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

3.  Shikonin inhibits invasiveness of osteosarcoma through MMP13 suppression.

Authors:  Biyong Deng; Bing Qiu
Journal:  Tumour Biol       Date:  2015-06-24

4.  Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo.

Authors:  Paul A Keire; Steven L Bressler; Eileen R Mulvihill; Barry C Starcher; Inkyung Kang; Thomas N Wight
Journal:  Matrix Biol       Date:  2015-12-23       Impact factor: 11.583

5.  MicroRNA-129-5p modulates epithelial-to-mesenchymal transition by targeting SIP1 and SOX4 during peritoneal dialysis.

Authors:  Li Xiao; Xun Zhou; Fuyou Liu; Chun Hu; Xuejing Zhu; Ying Luo; Ming Wang; Xiaoxuan Xu; Shikun Yang; Yashpal S Kanwar; Lin Sun
Journal:  Lab Invest       Date:  2015-05-11       Impact factor: 5.662

6.  Overexpression of miR-100 inhibits growth of osteosarcoma through FGFR3.

Authors:  Yunlong Bi; Yu Jing; Yang Cao
Journal:  Tumour Biol       Date:  2015-05-29

Review 7.  MicroRNA-143 expression inhibits the growth and the invasion of osteosarcoma.

Authors:  Pei Zhang; Jiale Zhang; Huahong Quan; Jingcheng Wang; Yuan Liang
Journal:  J Orthop Surg Res       Date:  2022-04-13       Impact factor: 2.359

8.  miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway.

Authors:  Ming He; Guangbin Wang; Linlin Jiang; Chuang Qiu; Bin Li; Jiashi Wang; Yonghui Fu
Journal:  Int J Oncol       Date:  2017-03-22       Impact factor: 5.650

9.  miR‑34c‑3p acts as a tumor suppressor gene in osteosarcoma by targeting MARCKS.

Authors:  Hongliang Liu; Pengxiao Su; Liqiang Zhi; Kai Zhao
Journal:  Mol Med Rep       Date:  2017-01-11       Impact factor: 2.952

10.  Glucocorticoids Improve Myogenic Differentiation In Vitro by Suppressing the Synthesis of Versican, a Transitional Matrix Protein Overexpressed in Dystrophic Skeletal Muscles.

Authors:  Natasha McRae; Leonard Forgan; Bryony McNeill; Alex Addinsall; Daniel McCulloch; Chris Van der Poel; Nicole Stupka
Journal:  Int J Mol Sci       Date:  2017-12-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.